SCHEMBL25220996

SCHEMBL25220996

CNCC(C)(C)C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.51
▸ KMT2A Q03164 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ PRSS1 P07477 1/20 0.45
▸ CTSG P08311 1/20 0.45
▸ CTRB1 P17538 1/20 0.45
▸ CMA1 P23946 1/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ LMNA P02545 2/20 0.43
▸ HCAR2 Q8TDS4 1/20 0.42
▸ PTPN1 P18031 1/20 0.42
▸ MMP8 P22894 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30443941 0.82 PPID (0.39) ALDH1A1MAPK1L3MBTL1SMN1; SMN2NPC1
SCHEMBL116845 0.81 ALDH1A1 (0.56) ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2
SCHEMBL28371759 0.81 ALDH1A1 (0.56) ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2
SCHEMBL621696 0.81 ALDH1A1 (0.56) ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2
SCHEMBL19957917 0.81 ALDH1A1 (0.49) ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2
SCHEMBL4181948 0.81 SYK (0.57) ALDH1A1KMT2ASMN1; SMN2MEN1PRSS1
SCHEMBL25576433 0.81 ALDH1A1 (0.51) ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2
SCHEMBL19527190 0.80 ALDH1A1 (0.47) ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2
SCHEMBL3295596 0.80 ALDH1A1 (0.55) ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2
SCHEMBL2127059 0.80 ALDH1A1 (0.55) ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4188551-B1 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF BAYER AG (DE) 2024-12-18 — — EP disclosed
US-12036783-B2 Pretreatment liquid, ink set, and image recording method FUJIFILM CORPORATION (JP) 2024-07-16 — — US disclosed
US-20230322767-A1 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF THE BROAD INSTITUTE, INC. 2023-10-12 — — US disclosed
US-20230322767-A1 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF THE BROAD INSTITUTE, INC. 2023-10-12 — — US disclosed
EP-4188551-A1 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF Bayer Aktiengesellschaft (DE) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322767-A1 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF PNPO, THPO, PAH ALDH1A1 249/4885KMT2A 4552/4885MAPK1 3076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback